Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Clinical Chemistry
|
November 9, 2000
Inaccuracy of calculated LDL-cholesterol in type 2 diabetes: consequences for patient risk classification and therapeutic decisions
A M Wägner, J L Sánchez-Quesada, A Pérez, et al.
Diabetologia
|
July 14, 1998
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
A Chico, A Pérez, A Córdoba, et al.
Clinical Chemistry
|
January 10, 2001
Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C Plus assay?
J Ordóñez-Llanos, A M Wägner, R Bonet-Marqués, et al.
Clinical Biochemistry
|
November 14, 2000
Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction
C Virgos, J Joven, J M Simó, et al.
Clinical Chemistry and Laboratory Medicine
|
September 24, 1998
Molecular diagnosis of lecithin: cholesterol acyltransferase deficiency in a presymptomatic proband
S Cirera, J Julve, I Ferrer, et al.
Metabolism: Clinical and Experimental
|
November 13, 2004
Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism
A Pérez, J M Cubero, N Sucunza, et al.
The American Journal of Cardiology
|
September 25, 1999
Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia
J L Sánchez-Quesada, C Otal-Entraigas, M Franco, et al.
The British Journal of Nutrition
|
October 14, 2009
Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice
J Méndez-González, S Süren-Castillo, L Calpe-Berdiel, et al.
European Journal of Internal Medicine
|
November 17, 2001
Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patients
A M Wägner, J Ordóñez-Llanos, M Hernández, et al.
The Journal of Biological Chemistry
|
March 22, 1996
Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
A Marzal-Casacuberta, F Blanco-Vaca, B Y Ishida, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Clinical Chemistry
|
November 9, 2000
Inaccuracy of calculated LDL-cholesterol in type 2 diabetes: consequences for patient risk classification and therapeutic decisions
A M Wägner, J L Sánchez-Quesada, A Pérez, et al.
Diabetologia
|
July 14, 1998
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
A Chico, A Pérez, A Córdoba, et al.
Clinical Chemistry
|
January 10, 2001
Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C Plus assay?
J Ordóñez-Llanos, A M Wägner, R Bonet-Marqués, et al.
Clinical Biochemistry
|
November 14, 2000
Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction
C Virgos, J Joven, J M Simó, et al.
Clinical Chemistry and Laboratory Medicine
|
September 24, 1998
Molecular diagnosis of lecithin: cholesterol acyltransferase deficiency in a presymptomatic proband
S Cirera, J Julve, I Ferrer, et al.
Metabolism: Clinical and Experimental
|
November 13, 2004
Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism
A Pérez, J M Cubero, N Sucunza, et al.
The American Journal of Cardiology
|
September 25, 1999
Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia
J L Sánchez-Quesada, C Otal-Entraigas, M Franco, et al.
The British Journal of Nutrition
|
October 14, 2009
Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice
J Méndez-González, S Süren-Castillo, L Calpe-Berdiel, et al.
European Journal of Internal Medicine
|
November 17, 2001
Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patients
A M Wägner, J Ordóñez-Llanos, M Hernández, et al.
The Journal of Biological Chemistry
|
March 22, 1996
Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
A Marzal-Casacuberta, F Blanco-Vaca, B Y Ishida, et al.
Page
of 6